Bi-specific antibodies are a new class of therapeutic molecules that are designed to bind two different antigens simultaneously. Bi-specific antibodies are becoming increasingly popular for the treatment of a wide range of diseases including cancer, autoimmune disorders, and infectious diseases.

Yurogen can reform any pair of antibodies into a bi-specific format as illustrated below. Our expertise guarantees the project is completed in a timely and efficient manner while maintaining high quality.